Field trial of an inactivated vaccine against hemorrhagic fever with renal syndrome in humans

  • Ho Wang Lee
  • C. N. Ahn
  • J. W. Song
  • L. J. Baek
  • T. J. Seo
  • S. C. Park
Part of the Archives of Virology Supplementum book series (ARCHIVES SUPPL, volume 1)


Hantaan virus was serially passaged in the brains of suckling rats. Vaccine inactivated with formalin was prepared from the suckling rat brains and the antigenic potency of the vaccine was determined by enzyme-linked immunosorbent assay (ELISA). Mice immunized with the vaccine were protected when challenged with live Hantaan virus. The antibody responses of 456 vaccinees given inactivated Hantaan virus vaccine against hemorrhagic fever with renal syndrome (HFRS) were then studied. Subcutaneous injection of the vaccine was better than intramuscular injection for production of antibodies in humans. Optimal immunogenic dose of the vaccine given subcutaneously to humans was 5,120 ELISA antigen units. Of 456 vaccinees, immunization of 336 with two doses of vaccine at one month interval resulted in 99% seroconversion by indirect immunofluorescent antibody tests. The vaccine was safe and only minimum side effects were observed. The efficacy of this vaccine against HFRS in the endemic areas of HFRS remains to be determined.


Japanese Encephalitis Japanese Encephalitis Hemorrhagic Fever With Renal Syndrome Seroconversion Rate Vaccine Preparation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    LeDuc JW, Smith GA, Childs JE, Pinheiro FP, Maiztegui JI, Niklasson B, Antoniadis A, Robinson DM, Khin M, Shortridge KF, Wooster MT, Elwell MR, Ilbery PLT, Koech D, Rosa EST, Rosen L (1986) Global survey of antibody to Hantaanrelated viruses among peridomestic rodents. Bull WHO 64: 139–144PubMedGoogle Scholar
  2. 2.
    Lee HW (1989) Hemorrhagic fever with renal syndrome in Korea. Rev Infect Dis 2: S864 - S876Google Scholar
  3. 3.
    Lee HW, Ahn CN (1988) Development of a vaccine against hemorrhagic fever with renal syndrome. J Kor Soc Virol 18: 143–148Google Scholar
  4. 4.
    Lee HW, Lee PW (1976) Korean hemorrhagic fever. I. Demonstration of causative antigen and antibodies. Kor J Intern Med 19: 371–394.Google Scholar
  5. 5.
    Lee HW, Lee PW, Johnson KM (1978) Isolation of the etiologic agent of Korean hemorrhagic fever. J Infect Dis 137: 298–308.PubMedCrossRefGoogle Scholar
  6. 6.
    Lee HW, van der Groen G (1989) Hemorrhagic fever with renal syndrome. Prog Med Virol 36: 62–102PubMedGoogle Scholar
  7. 7.
    Lee PW, Gibbs CJ, Gajdusek DC, Svedmyr A (1981) Antibody to Korean hemorrhagic fever virus in man in parts of the world where hemorrhagic fever with renal syndrome is not known. Lancet 1: 256–257Google Scholar
  8. 8.
    Lee PW, Meegan JM, LeDuc JW, Tkachenko EA, Tvanov AP, Rezapkin GV, Drozdov SG, Kitamura T, Tsai TF, Dalrymple JM (1989) Serologic techniques.for detection of Hantaan virus infection, related antigens and antibodies. In: Lee HW, Dalrymple JM (eds) Manual of hemorrhagic fever with renal syndrome. WHO Collaborating Centre for Virus Reference and Research (HFRS), Institute for Viral Diseases, Korea University, Seoul, pp 75–106Google Scholar
  9. 9.
    Lowry OH, Rosenbrough NG, Farr AL, Randall RG (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–269PubMedGoogle Scholar
  10. 10.
    Oya A (1987) New development of criteria on Japanese encephalitis vaccine requirements in Japan. WHO Japanese encephalitis and hemorrhagic fever with renal syndrome Bull 2: 11–13Google Scholar
  11. 11.
    Schmaljohn CS, Hasty SE, Dalrymple JM, LeDuc JW, Lee HW, von Bonsdorff CH, Brummer-Korvenkontio M, Vaheri A, Tsai TF, Regnery HL, Goldgaber D, Lee PW (1985) Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 227: 1041–1044PubMedCrossRefGoogle Scholar
  12. 12.
    Weeke B, Weeke E, Lowenstein H (1975) The adsorption of serum protein to aluminum hydroxide gel examined by means of quantitative immunoelectrophoresis. Scand J Immunol 4 [Suppl 2]: 149–154CrossRefGoogle Scholar
  13. 13.
    Yamanishi K, Tomishita O, Tamura M (1988) Development of inactivated vaccine against virus causing hemorrhagic fever with renal syndrome. Vaccine 6: 278–282PubMedCrossRefGoogle Scholar
  14. 14.
    National Institute of Preventive Medicine and Hygiene Japan (1976) Preparation of Japanese encephalitis vaccine. In: Yanagizawa G (ed) Vaccines in Japan, 2nd edn. Maruzen, Tokyo, pp 80–85Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • Ho Wang Lee
    • 1
    • 2
  • C. N. Ahn
    • 3
  • J. W. Song
    • 1
  • L. J. Baek
    • 1
  • T. J. Seo
    • 4
  • S. C. Park
    • 4
  1. 1.The Institute for Viral DiseasesKorea UniversitySeoulKorea
  2. 2.The Institute for Viral DiseasesKorea UniversitySeoulKorea
  3. 3.Mogam Biotechnology Research InstituteKyunggi-doKorea
  4. 4.Korea University HospitalSeoulKorea

Personalised recommendations